Eric Belair · Associate Assistant Deputy Minister, Health Canada (HC)
Modernization of food regulations and legislation - advocate to ensure modernization efforts are supportive of innovation for plant-based foods and include improvements to the transparency and timeliness of food approvals for novel foods, infant formula, food additives and health claims.Read more
Ensuring that food and drugs regulation and policy reflect the need for a relative risk approach.
Karl Van Kessel · Director North American Trade Policy Division, Global Affairs Canada (GAC)
Sabina Dadrian-Kassabian · Deputy Director, North American Trade Policy Division, Global Affairs Canada (GAC)
Providing input to government on rules-based trade and e-commerce: working to ensure that international trade allows for the predictable flow of ingredients, products and people; addressing the rise of non-compliant and illicit products from entering the Canadian market; and advocating against protectionism (including new tariffs).Read more
Canada's ongoing involvement in CUSMA and rules-based trade with a specific interest in sectoral tariffs imposed by the United States and counter tariffs imposed by Canada.
Modernization of food regulations and legislation - advocate to ensure modernization efforts are supportive of innovation for plant-based foods and include improvements to the transparency and timeliness of food approvals for novel foods, infant formula, food additives and health claims.
Roy Karam · Advisor, Economic and Health System Policy, Health Canada (HC)
Modernization of food regulations and legislation - advocate to ensure modernization efforts are supportive of innovation for plant-based foods and include improvements to the transparency and timeliness of food approvals for novel foods, infant formula, food additives and health claims.Read more
Modernization of food regulations and legislation - advocate to ensure modernization efforts are supportive of innovation for plant-based foods and include improvements to the transparency and timeliness of food approvals for novel foods, infant formula, food additives and health claims.Read more
Lisa Xie · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
René Sylvestre · Director of Strategic Investment, Innovation, Science and Economic Development Canada (ISED)
Canada's ongoing involvement in CUSMA and rules-based trade with a specific interest in sectoral tariffs imposed by the United States and counter tariffs imposed by Canada.Read more
Manufacturing Incentives – Working to shape policies and programs to support innovation, competitiveness and growth for manufacturers.
Canada's ongoing involvement in CUSMA and rules-based trade with a specific interest in sectoral tariffs imposed by the United States and counter tariffs imposed by Canada.Read more
Competitiveness – providing input to ensure that Canada's food, health and consumer manufacturing sector is competitive throughout the whole supply chain.
Ensuring consumer choice and access to non-prescription drugs (over the counter and natural health products) regulated under the Food and Drugs Act.Read more
Manufacturing Incentives – Working to shape policies and programs to support innovation, competitiveness and growth for manufacturers.
Sean O'Neill · Director of Parliamentary Affairs, Finance Canada (FIN)
Canada's ongoing involvement in CUSMA and rules-based trade with a specific interest in sectoral tariffs imposed by the United States and counter tariffs imposed by Canada.Read more
Sean O'Neill · Director of Parliamentary Affairs, Finance Canada (FIN)
Providing input to government on rules-based trade and e-commerce: working to ensure that international trade allows for the predictable flow of ingredients, products and people; addressing the rise of non-compliant and illicit products from entering the Canadian market; and advocating against protectionism (including new tariffs).Read more
Galen Richardson · Director of Stakeholder Relations, Privy Council Office (PCO)
Providing input to government on rules-based trade and e-commerce: working to ensure that international trade allows for the predictable flow of ingredients, products and people; addressing the rise of non-compliant and illicit products from entering the Canadian market; and advocating against protectionism (including new tariffs).Read more
Shannon Ablett · Stakeholder Relations Manager, Privy Council Office (PCO)
Canada's ongoing involvement in bilateral and multilateral free trade arrangements, with specific interest in measures affecting the protection of intellectual property.Read more
Measures to facilitate internal trade in Canada, including through Bill C-5, the One Canadian Economy Act.Read more
Communicating with government officials about recycling and circular economy initiatives, including as it relates to Extended Producer Responsibility ("EPR") obligations for manufacturers.
Ensuring consumer choice and access to non-prescription drugs (over the counter and natural health products) regulated under the Food and Drugs Act.
Justine Frame · Policy Advisor, Health Canada (HC)
Ensuring consumer choice and access to non-prescription drugs (over the counter and natural health products) regulated under the Food and Drugs Act.Read more
Ensuring that food and drugs regulation and policy reflect the need for a relative risk approach.
Ensuring that the Food and Drugs Act recognizes the need for relative risk based regulation.
Julian Tabbitt · Legislative Assistant, House of Commons
Communications with regard to retail theft of consumer health products and e-marketplaces and concerns around product safety and product integrity resulting from e-theft.Read more
Shannon Ablett · Stakeholder Relations Manager, Privy Council Office (PCO)
Élysée Atangana · Policy Advisor, Privy Council Office (PCO)
Ensuring consumer choice and access to non-prescription drugs (over the counter and natural health products) regulated under the Food and Drugs Act.Read more
Seeking harmonization of regulatory regimes and administrative processes nationally and internationally.
Shalene Curtis-Micallef · Deputy Minister, Health Canada (HC)
Pamela Aung-Thin · Associate Deputy Minister of Health, Health Canada (HC)
Ensuring that food and drugs regulation and policy reflect the need for a relative risk approach.Read more
Ensuring that the Food and Drugs Act recognizes the need for relative risk based regulation.
Modernization of food regulations and legislation - advocate to ensure modernization efforts are supportive of innovation for plant-based foods and include improvements to the transparency and timeliness of food approvals for novel foods, infant formula, food additives and health claims.
Regulations Amending the Food and Drugs Regulations - Nutritional Labelling, Other Labelling Provisions and Food Colours – continue to engage with government to ensure clarity on compliance and enforcement of regulations.
Food and Drug Regulations with regard to the Addition of Vitamins and Minerals to Food (Fortification) - Discretionary fortification will provide opportunities for product innovation in the food manufacturing industry.
Roy Karam · Senior Policy Advisor, Health Canada (HC)
Providing input to government on regulatory modernization initiatives, including encouraging the enforcement of an economic lens to the design and implementation of all regulations.Read more
Modernization of food regulations and legislation - advocate to ensure modernization efforts are supportive of innovation for plant-based foods and include improvements to the transparency and timeliness of food approvals for novel foods, infant formula, food additives and health claims.
Bill C-224 - An Act to amend the Food and Drugs Act (natural health products): To keep NHPs under the purview of the Food and Drugs Act (i.e. Vanessa’s Law), which gives the minister the authority to use a ministerial order for a number of reasons (product recall, delay cost-recovery NHPs, delay labelling for NHPs to a later date).Read more
Bill C-224 - An Act to amend the Food and Drugs Act (natural health products): To keep NHPs under the purview of the Food and Drugs Act (i.e. Vanessa’s Law), which gives the minister the authority to use a ministerial order for a number of reasons (product recall, delay cost-recovery NHPs, delay labelling for NHPs to a later date).Read more
Bill C-224 - An Act to amend the Food and Drugs Act (natural health products): To keep NHPs under the purview of the Food and Drugs Act (i.e. Vanessa’s Law), which gives the minister the authority to use a ministerial order for a number of reasons (product recall, delay cost-recovery NHPs, delay labelling for NHPs to a later date).Read more
Paul Moen · Chief of Staff, Innovation, Science and Economic Development Canada (ISED)
Guy Gallant · Chief of Staff, Agriculture and Agri-Food Canada (AAFC)
National Food Policy – Working in consultation with Agriculture and Agri-Food Canada as the National Food Policy, designed to address issues related to production, processing, distribution and consumption of food, is developed and implemented.Read more
Manufacturing Incentives – Working to shape policies and programs to support innovation, competitiveness and growth for manufacturers.
Seeking harmonization of regulatory regimes and administrative processes nationally and internationally.
Providing input to government on regulatory modernization initiatives, including encouraging the enforcement of an economic lens to the design and implementation of all regulations.
Labour & Skills shortages – Working to shape policies and programs to address labour and skills shortages facing Canada’s manufacturing sector.
Competitiveness – providing input to ensure that Canada's food, health and consumer manufacturing sector is competitive throughout the whole supply chain.
Bill C-224 - An Act to amend the Food and Drugs Act (natural health products): To keep NHPs under the purview of the Food and Drugs Act (i.e. Vanessa’s Law), which gives the minister the authority to use a ministerial order for a number of reasons (product recall, delay cost-recovery NHPs, delay labelling for NHPs to a later date).Read more
Bill C-224 - An Act to amend the Food and Drugs Act (natural health products): To keep NHPs under the purview of the Food and Drugs Act (i.e. Vanessa’s Law), which gives the minister the authority to use a ministerial order for a number of reasons (product recall, delay cost-recovery NHPs, delay labelling for NHPs to a later date).Read more
Bill C-224 - An Act to amend the Food and Drugs Act (natural health products): To keep NHPs under the purview of the Food and Drugs Act (i.e. Vanessa’s Law), which gives the minister the authority to use a ministerial order for a number of reasons (product recall, delay cost-recovery NHPs, delay labelling for NHPs to a later date).Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence.
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.